Allergan plc (NYSE:AGN)

184.50
Delayed Data
As of Nov 18
 +0.89 / +0.48%
Today’s Change
114.27
Today|||52-Week Range
184.92
+38.04%
Year-to-Date
Editas Expands Its Celgene Partnership After Another Strong Quarter
Nov 13 / MotleyFool.com - Paid Partner Content
This Terrific High-Yield Dividend Stock Just Got Even Better
Nov 10 / MotleyFool.com - Paid Partner Content
Why Does AbbVie Pay a Much Higher Dividend Than Its Peers?
Nov 13 / MotleyFool.com - Paid Partner Content
Up 19.2%, Is Viking Therapeutics Stock Still a Buy?
Nov 06 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close183.61
Today’s open183.45
Day’s range183.22 - 184.92
Volume2,890,836
Average volume (3 months)3,187,058
Market cap$60.3B
Data as of 6:30pm ET, 11/18/2019

Growth & Valuation

Earnings growth (last year)-15.70%
Earnings growth (this year)+1.21%
Earnings growth (next 5 years)+6.10%
Revenue growth (last year)-0.96%
P/E ratioNM
Price/Sales2.85
Price/Book0.94

Competitors

----
TAKTakeda Pharmaceutica...+0.27+1.33%
ZTSZoetis Inc+0.88+0.75%
VRTXVertex Pharmaceutica...+0.20+0.10%
Data as of 6:30pm ET, 11/18/2019

Financials

Next reporting dateFebruary 19, 2020
EPS forecast (this quarter)$4.52
Annual revenue (last year)$15.8B
Annual profit (last year)-$5.1B
Net profit margin-32.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
No executives to display
Corporate headquarters
Dublin, Dublin

Forecasts